L3 Effectiveness of Influenza Vaccines Against Pandemic H1N1 Among Children

Thursday, March 31, 2011: 10:30 AM-11:30 AM
Jefferson
Presenters in this workshop will discuss the effectiveness of the 2009 H1N1 monovalent influenza vaccine. Various methods for evaluating the success of influenza vaccine programs will be explored.
Moderator:
Joseph Bresee

10:30 AM
Effectiveness of One Dose of 2009 Monovalent H1N1 Vaccine at Preventing Hospitalization with Pandemic H1N1 Influenza In Children 7 Months to 9 Years of Age, New York City
James Hadler, MD, MPH, Public Health Consultant, New York City Department of Health and Mental Hygiene; Tai Baker, MPH, CHES; Vikki Papadouka, PhD, MPH; Anne Marie France, PhD; Christopher M. Zimmerman, MD, MPH; Kara Livingston, MPH; Jane R. Zucker, MD, MSc
11:00 AM
Various Measures of the Effectiveness of 2009 H1N1 Influenza Vaccination Among Children Vaccinated at School During the 2009 Influenza Pandemic In Maine
Ricardo Basurto-Davila, PhD, MS, Prevention Effectiveness Fellow, Centers for Disease Control and Prevention; Mark Thompson, PhD; Nancy Dube, RN, MPH; Sandra Chaves, MD, MSc; Jill Ferdinands, PhD; Samuel Graitcer, MD; Lydia Foster, MS; Peter Smith, PhD; Amra Uzicanin, MD, MPH; Meredith Tipton, PhD, MPH; Jufu Chen, PhD; Paul Gargiullo, PhD; Rebel Jackson, RN, NCSN, MPA; Arnold Monto, MD, MPH; David Shay, MD, MPH
See more of: Submissions